Physician profile
Jesse Thomas Lyon
NPI 1013431188
$28,054.65
in general payments reported to CMS, 2019-2025
41 companies · $2,858 in 2025
The $2,858 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,923 · 2022: $2,074 · 2023: $6,068 · 2024: $15K · 2025: $2,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $3,722 · Travel and Lodging: $2,716 · Honoraria: $1,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,825.00 |
| Food and Beverage | $3,722.39 |
| Travel and Lodging | $2,716.12 |
| Honoraria | $1,793.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $14,793.96 | 2021-2025 | Korlym |
| Xeris Pharmaceuticals, INC. | $8,677.49 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Novo Nordisk INC | $595.97 | 2021-2025 | Sogroya, Wegovy, Ozempic |
| Insulet Corporation | $548.54 | 2021-2025 | Omnipod, Omnipod |
| Abbott Laboratories | $398.64 | 2021-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $386.66 | 2021-2023 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $249.22 | 2021-2022 | |
| Lilly USA, LLC | $242.17 | 2021-2023 | Jardiance, Mounjaro |
| Abbvie INC. | $177.36 | 2021-2025 | |
| Horizon Therapeutics Plc | $153.07 | 2021-2023 | Tepezza |
| Medtronic, INC. | $136.77 | 2021-2024 | Minimed 780g |
| Beta Bionics, INC. | $127.80 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Alexion Pharmaceuticals, INC. | $124.55 | 2021-2023 | Strensiq |
| Dexcom, INC. | $118.77 | 2022-2023 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $118.50 | 2021-2023 | Tlando, Nocdurna, Xyosted |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Lyon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.